n.— «“Clinical research and translational research is down 70% in the U.S.,” he tells me, laying out two primary explanations: First, he blames “the lobbies, restrictions, confidentiality problems, insurance companies regulating what needs to be done, what can be done, what cannot be done…the usual ambulance chasing that occurs.”» —“Why Clinical Research in India Outpaces U.S.” by Amar C. Bakshi Washington Post June 26, 2007. (source: Double-Tongued Dictionary)

Tagged with →